Encompass Health Plans a 50-Bed Unit to Better Serve North Las Vegas

Encompass Health (EHC) plans to open a 50-bed inpatient rehabilitation hospital in North Las Vegas by 2028, expanding its Nevada presence and national network of 168 facilities. This move aligns with EHC's growth strategy to meet increasing demand for rehabilitation services, which drove a 10.6% year-over-year revenue increase in Q1 2025; EHC shares have outperformed the industry, gaining 41.8% in the past year.

Analysis

Encompass Health Corporation (EHC) has detailed plans for a new 50-bed inpatient rehabilitation hospital in North Las Vegas, expected to be operational by 2028, further expanding its existing network of 168 facilities and strengthening its market position in Nevada. This development is consistent with EHC's broader strategy to meet the growing nationwide demand for rehabilitation services, which contributed to a 10.6% year-over-year increase in its inpatient rehabilitation revenues to $1.5 billion in Q1 2025. The company's combined approach of de novo facility construction and strategic partnerships, such as the recent Fort Myers hospital with Lee Health, underpins its robust growth, evidenced by a 41.8% share price increase over the past year, significantly outperforming the industry's 3.6% rise, and its current Zacks Rank #1 (Strong Buy) status. The article also points to other Zacks Rank #1 stocks in the medical sector, Integer Holdings (ITGR) and BioLife Solutions (BLFS), as having strong earnings outlooks, while Align Technology (ALGN), also a #1 Rank, has consistently beaten earnings estimates despite recent share price underperformance.

Key Decisions for Investors

• Given Encompass Health's consistent revenue growth, strategic expansion initiatives like the planned Las Vegas hospital, and significant share price outperformance (41.8% in past year) supported by a Zacks #1 Rank, investors should consider the stock favorably for continued growth within the healthcare services sector.
• It is advisable to monitor EHC’s execution on its facility development pipeline, including the 2028 timeline for the new Nevada hospital, and track patient volume trends as key indicators of sustained operational performance and revenue generation.
• For investors seeking broader exposure to top-ranked medical stocks, further due diligence on Integer Holdings and BioLife Solutions is warranted based on their positive earnings forecasts and recent estimate revisions, while Align Technology may present a value opportunity given its strong earnings beats despite recent share price declines.